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Abstract: 
Background and Objectives: Poly-substance use and psychiatric comorbidity are common among 
individuals receiving substance detoxification services. Posttraumatic stress disorder (PTSD) and 
major depressive disorder (MDD) are the most common co-occurring psychiatric disorders with 
substance use disorder (SUD). Current treatment favors a one-size-fits-all approach to treating 
addiction focusing on one substance or one comorbidity. Research examining patterns of 
substance use and comorbidities can inform efforts to effectively identify and differentially treat 
individuals with co-occurring conditions.  
Methods: Using latent class analysis, the current study identified four patterns of PTSD, MDD, 
and substance use among 375 addiction treatment seekers receiving medically supervised 
detoxification.  
Results: The four identified classes were: 1) a PTSD-MDD-Poly SUD class characterized by 
PTSD and MDD occurring in the context of opioid, cannabis, and tobacco use disorders; 2) an 
MDD-Poly SUD class characterized by MDD and alcohol, opioid, tobacco, and cannabis use 
disorders; 3) an alcohol-tobacco class characterized by alcohol and tobacco use disorders; and 4) 
an opioid-tobacco use disorder class characterized by opioid and tobacco use disorders. The 
observed classes differed on gender and clinical characteristics including addiction severity, 
trauma history, and PTSD/MDD symptom severity.  
Discussion and Conclusions:  The observed classes likely require differing treatment approaches. 
For example, people in the PTSD-MDD-Poly SUD class would likely benefit from treatment 
approaches targeting anxiety sensitivity and distress tolerance, while the opioid-tobacco class 
would benefit from treatments that incorporate motivational interviewing. Appropriate matching 
of treatment to class could optimize treatment outcomes for polysubstance and comorbid 
psychiatric treatment seekers. These findings also underscore the importance of well-developed 
referral networks to optimize outpatient psychotherapy for detoxification treatment-seekers to 
enhance long-term recovery, particularly those that include transdiagnostic treatment 
components. 
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Patterns of Co-Occurring Addictions, PTSD, and MDD in Detoxification Treatment Seekers:  
Implications for Improving Detoxification Treatment Outcomes 
1. Introduction 
Psychiatric comorbidity is highly prevalent in addiction treatment seekers; for instance, 
11-41% of people seeking treatment for a substance use disorder (SUD) also meet criteria for 
posttraumatic stress disorder (PTSD: Read, Brown, & Kahler, 2004). SUD-PTSD comorbidity is 
especially noteworthy as this comorbidity is associated with more intense cravings and higher 
rates of relapse following addiction treatment (Berenz & Coffey, 2012) than is SUD alone. Both 
PTSD and SUD are associated with increased risk for major depressive disorder (MDD: Lai, 
Cleary, Sitharthan, & Hunt, 2015). Further, PTSD or SUD comorbid with MDD is associated 
with more severe psychosocial impairment than either PTSD or SUD alone (Erfan, Hashim, 
Shaheen, & Sabry, 2010). Difficulties in treating SUD comorbidities may be exacerbated in the 
detoxification setting where treatment seekers may have different motivations and priorities than 
those in traditional outpatient settings (Freyer-Adam, Gaertner, Rumpf, John, & Hapke, 2010). 
Indeed, the few differential predictors of SUD treatment outcome identified in Project MATCH 
are characteristics that are more common in PTSD-SUD samples: more severe psychopathology 
and anger (Coffey, Schumacher, Brimo, & Brady, 2005). The goal of this study was to identify 
comorbidity profiles in a special population of people who use substances, detoxification 
treatment seekers, in order to inform integrative SUD-comorbidity treatment protocols. 
Given the prevalence and negative sequelae of psychiatric comorbidity in addiction 
treatment seekers, current practice guidelines recommend integrative treatments that address 
both addiction problems and co-occurring psychiatric problems throughout the course of 
treatment (SAMHSA, 2006). Integrated protocols often consist of cognitive behavioral therapy 
(CBT) combined with motivational interviewing techniques or a combination of different CBT 
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protocols. Although integrative treatments are the most efficacious option, many patients still do 
not respond to these treatments, leaving room for improvement and innovation (Hien et al., 
2009). Currently, there is no established standard regarding what components, treatment targets, 
or number of sessions to include in integrative treatment protocols. Often providers are left to 
make educated guesses about these important decisions. Research targeted towards better 
understanding subgroups of detoxification seekers is important to highlight potential differences 
that can be targeted in treatment. Yet, detoxification seekers have often been excluded from large 
scale psychotherapy outcome research making it unclear how results from prior patient 
characteristic/treatment matching research apply to this group (Project MATCH, 1997). 
One area of clarity in treatment guidelines is the necessity of delivering treatment for an 
appropriate duration – a challenge in the detoxification setting given that treatment goals in this 
context are focused on medically stabilizing patients from extreme use (SAMHSA, 2006). 
Despite this challenge, detoxification facilities, as the entry point into addiction treatment, are 
also in a unique position to increase patient success. Detoxification facilities can make long-term 
treatment recommendations following stabilization that are individualized to the unique needs 
and problem areas experienced by patients. People seeking treatment at detoxification centers 
may be more motivated for treatment (Freyer-Adam et al., 2010); yet, people with comorbidities 
are more likely to drop out of treatment than people without comorbidities, emphasizing the need 
to match comorbidity profiles to post-detox referral patterns (Tómasson & Vaglum, 1998).  
In addition to psychiatric comorbidities, polysubstance use also creates challenges for 
treatment. Polysubstance use is associated with more severe addiction problems (Moss, 
Goldstein, Chen, & Yi, 2015), more frequent emergency department admissions (Tait, Hulse, 
Robertson, & Sprivulis, 2005), greater risk of both non-fatal and fatal overdose (Darke et al., 
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2014), greater dropout in detox settings (Tómasson & Vaglum, 1998), and greater risk for 
relapse following treatment than outcomes for people who use a single substance (Branson, 
Clemmey, Harrell, Subramaniam, & Fishman, 2012). Furthermore, polysubstance use is 
associated with increased rates of both MDD and PTSD than rates of these disorders among 
people who use a single substance (Conway et al., 2013); this is particularly true among those 
who have experienced interpersonal violence (Ullman & Long, 2008).  
Many forms of interpersonal violence disproportionately affect more women than men 
(Black et al., 2011); which likely contributes to gender-related PTSD-SUD disparities. Women 
often present with more complex psychiatric symptoms and severe symptoms than men, related 
to higher rates of interpersonal violence including rape (Najavits, Weiss, & Shaw, 1997). 
Although women are more likely to have PTSD, men are more likely to seek treatment for SUDs 
(Najavits, Weiss, & Shaw, 1997; Cohen, Feinn, Arias, Kranzler, 2007). These findings 
underscore the importance of examining gender differences in studies of psychiatric and SUD 
comorbidity.   
Latent class analysis (LCA) is a person-centered statistical technique that identifies 
subgroups of individuals who share common values on some set of variables. This feature makes 
it an ideal tool for examining patterns of polysubstance use and psychiatric comorbidity in 
people who use substances. Furthermore, in the context of detoxification treatment, it can inform 
the referral process used to determine appropriate treatment options following medical 
stabilization by identifying subgroups of patients with common problem areas. Research using 
LCA in SUD populations has typically identified three classes: a limited involvement class 
(characterized by alcohol, tobacco, and marijuana use); a moderate involvement class 
(characterized by substance use including alcohol, tobacco, marijuana, and amphetamine use); 
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and an extended involvement class (characterized by the use of a large number of substances 
including alcohol, tobacco, marijuana, amphetamines, non-medical prescription drugs, and other 
illicit drugs). Members of the extended involvement class tend to have elevated levels of anxiety 
and depression (Connor et al., 2013). Yet, most research conducting LCAs in people who use 
substances has not examined PTSD as a comorbid diagnosis. Further, when studies have 
examined PTSD it was as a covariate, rather than as an indicator variable (a variable used to 
define classes). This conceptual difference can dramatically impact findings – considering PTSD 
as an indicator suggests that PTSD is considered to have a possible shared etiology while 
considering it as a covariate suggests that PTSD is considered more a post-hoc complication. 
Utilizing PTSD as a covariate is contrary to the tension-reduction model of PTSD-SUD 
comorbidity which postulates that SUD problems develop after a traumatic event as part of a 
maladaptive coping process (Berenz & Coffey, 2012).  
Despite the growing literature applying LCA to polysubstance use and comorbid 
psychiatric disorders, limited research has attempted to identify subgroups of people in 
detoxification treatment-seekers. As described, this is a substantial limitation given that class 
identification in this unique population can inform treatment and referral approaches which may 
be especially important in a short-term setting.  
1.1 Current Study 
The current study used LCA to examine how PTSD, multiple SUDs, and MDD may co-
occur in a sample of adults seeking medically supervised detoxification. We specifically chose to 
focus on MDD as an additional comorbidity given the frequency of MDD diagnoses in relation 
to both PTSD and SUDs and is (Quello, Brady, Sonne, 2005; Dixon, Resick, & Nishith, 2005). 
We also sought to examine differences between LCA-identified subgroups on key clinical 
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characteristics relevant to PTSD, polysubstance use, or MDD including addiction problem 
severity, trauma history (i.e., sexual/physical assault in childhood vs. adulthood), and 
PTSD/MDD symptom severity. Finally, given established gender differences in the prevalence 
of psychiatric disorders, we also considered how the observed subgroups differed according to 
gender.  
Hypotheses: 
1. We hypothesized that multiple classes would be identified reflecting the complexity of 
psychiatric comorbidity and polysubstance use. 
2. We further hypothesized that classes with greater psychiatric comorbidity (i.e., greater 
proportion of probable PTSD diagnoses) would experience more severe addiction 
problems, greater trauma history, higher psychiatric symptom severity, and contain a 
larger proportion of women than other classes. 
2. Materials and Method 
2.1 Participants 
Participants were 375 adults seeking medically assisted detoxification at the inpatient unit 
of the Alcohol, Drug Addiction, and Mental Health Crisis Center in Northeast Ohio. This 
detoxification center is a private, non-profit organization providing both residential (i.e., 
inpatient medically assisted detoxification, housing for intoxicated individuals, etc.) and non-
residential (i.e., alcohol/drug addiction assessments and treatment referrals, group counseling, 
12-step meetings, etc.) services regardless of patients’ ability to pay. Participants were recruited 
within two days of their admission (M = 2.02, SD = 1.35) and, on average, participants spent 4.5 
days receiving treatment at the detoxification facility. Consistent with the detoxification center’s 
demographics (91% Caucasian, 65% male) participants largely identified as Caucasian (93.2%) 
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with 6.9% identifying as African-American, 0.5% Asian, and 6.9% identifying their ethnicity as 
Hispanic/Latino. The majority of participants were men (61.3%). The average age was 35.6 
years (SD = 11.4) and the average education level was 12.2 years (SD = 1.9). 
2.2 Procedure 
 Participants were approached and consented by research staff. Consenting participants 
completed a questionnaire battery. Demographic and SUD diagnosis data were collected by 
medical chart review. After survey completion, participants were provided with a choice of 
either a $5.00 gift card or a candy bar to compensate them for their time. Data were collected 
between February 2013 and April 2014. 
2.3 Materials  
2.3.1 Trauma history. Trauma history and Criterion A for the DSM-IV-TR definition of 
PTSD were assessed using the 21 traumatic event items from the Life Stressor Checklist-Revised 
(LSC-R: Wolfe, Kimerling, Brown, Chrestman, & Levin, 1996).  
2.3.2 PTSD. The PTSD Checklist-Civilian (PCL-C: Blanchard, Jones-Alexander, 
Buckley, & Forneris, 1996) was used to assess PTSD symptoms. The PCL-C is a 17-item 
measure that asks participants to rate how frequently they have experienced each of the 17 PTSD 
symptoms corresponding to DSM-IV-TR criteria. Participants were asked to rate how often or 
how much they had been bothered by each symptom in the past month on a scale ranging from 1 
(‘Not at all/never’) to 5 (‘Extremely/daily or almost daily’). In the present study, Cronbach’s 
alpha for the PCL-C was 0.96. Items from the well-validated Posttraumatic Diagnostic Scale 
(PDS: Foa, Cashman, Jaycox, & Perry, 1997) were included to assess impairment and duration 
of symptoms; responses to the PCL-C, LSC-R (for items related to criterion A) and PDS were 
combined to determine probable PTSD diagnostic status. Specifically, participants were 
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classified as having a probable PTSD diagnosis if they (a) reported experiencing at least one 
traumatic event meeting Criterion A as assessed by the LSC-R; (b) endorsed at least 1 re-
experiencing symptom, 3 avoidance symptoms, and 2 hyperarousal symptoms (symptom 
endorsement was defined as a rating of 3 or higher) on the PCL-C (NCPTSD, 2014); (c) reported 
experiencing these symptoms for at least 1 month; and (d) reported functional impairment in at 
least 1 domain (e.g., home, work, school, etc.) from endorsed symptoms on by the PDS.  
2.3.3 Depression. The Center for Epidemiologic Studies Depression Scale-Revised 
(CESD-R: Eaton, Smith, Ybarra, Muntaner, & Tien, 2004) was used to assess depression. In the 
present study, participants were asked to rate how often they had experienced each symptom in 
the past month (rather than the past week) on a scale ranging from 0 (‘Not at all or less than one 
day’) to 4 (‘Nearly every day for the past month’). In the present study, Cronbach’s alpha was 
0.94. Participants’ responses were used to determine both probable diagnostic levels of 
depression using the algorithmic classification scheme reported by Eaton et al. as well as to 
assess depression symptom severity.  
 2.3.4 SUDs. Licensed staff clinicians assessed SUDs at intake using the DSM Checklist 
for SUDs, a semi-structured interview that has demonstrated good reliability and validity 
(Hudziak et al., 1993). Substance use disorder diagnostic status for each of the following 
substances (opiates, alcohol, sedatives, amphetamines, cocaine, tobacco, and cannabis) was 
determined via chart review. 
 2.3.5 Problematic substance use. Problematic substance use was assessed using the 
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST: Ali et al., 2002). The 
ASSIST is a 6-item screening test that assesses difficulties arising from an individual’s use of 
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different psychoactive substances; the six items are assessed for each type of substance endorsed. 
Cronbach’s alpha for each substance subscale ranged from .62 (tobacco) - .95 (opioid). 
 2.3.6 Substance use consequences. Negative consequences related to substance use were 
assessed using the Shortened Inventory of Problems-Alcohol and Drugs (SIP-AD: Blanchard, 
Morgenstern, Morgan, Lobouvie, & Bux, 2003). The SIP-AD is a 15-item questionnaire that asks 
participants to rate how frequently they have experienced different negative consequences 
resulting from their alcohol or drug use. Items reflect a broad range of domains in which 
psychosocial impairment may be experienced including psychosocial relationships, financial 
responsibilities, physical health, etc. Each item is rated on a scale ranging from 0 (‘Never’) to 3 
(‘Daily or almost daily’). In the present study, Cronbach’s alpha was 0.93. 
2.4 Statistical analyses 
Latent class analysis (LCA) was used to characterize the patterns of co-occurring SUDs, 
PTSD, and MDD in the sample. LCA identifies latent classes or groups of participants based on 
a given set of indicator variables that are hypothesized to represent one or more latent variables. 
This analysis used nine indicator variables to determine class composition. Seven of these 
indicators were dichotomous SUD diagnoses (yes/no) as determined by chart review. Two 
additional indicator variables were probable PTSD and MDD diagnosis coded dichotomously 
using the algorithms described above.  
The LCA was conducted in an exploratory fashion using Mplus (Version 5.0). Multiple 
models were examined starting with a two class model and adding additional classes. Model fit 
was evaluated using a variety of statistical criteria including the Bayesian Information Criterion 
(BIC), sample size adjusted BIC (SSA-BIC), and Akaike Information Criterion (AIC) where 
smaller values indicate better fit. The model was also evaluated with the Lo-Mendell-Rubin test 
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(LMRT) and the bootstrap likelihood ratio test (BLRT) which indicate whether a model with k 
classes better fits the data than a model with k-1 classes. In other words, if the p-value is greater 
than 0.05 the model with k classes is not significantly different from the k-1 class and the more 
parsimonious model is preferred. Finally, model fit was also assessed via the entropy value, 
where values closer to 1.0 indicate better classification.  
Class proportions and conditional item probabilities for each indicator variable by class 
were then examined to determine the characteristics of observed classes. If 60% or more of the 
participants in a class had the characteristic, then the characteristic was said to be a 
distinguishing feature of the class (Galatzer‐Levy, Nickerson, Litz, & Marmar, 2013).  
Following the LCA, non-indicator variables, or external variables, were considered to 
evaluate the practical relevance and clinical significance of the best fitting solution. Pearson chi-
square analyses were used for dichotomous and categorical non-indicator variables while 
Tukey’s HSD/ Dunnett’s T3 post-hoc tests were used following statistically significant one-way 
ANOVAs for continuous non-indicator variables.  
3. Results 
3.1 Descriptive statistics 
 Trauma history was prevalent in the sample, with 91.8% meeting criteria for at least 1 
Criterion A event. On average, participants reported experiencing 4.6 (SD = 3.8) types of 
Criterion A events with the most commonly endorsed events consisting of witnessing a serious 
accident (48.1%), being in a serious accident (47.4%), and witnessing violence between family 
members before the age of 16 (38.2%).  
Prevalence rates for each diagnosis are listed in the right-hand column of Table 1. The 
average number of SUD diagnoses was 3.26 (SD = 1.32) with the most common diagnoses being 
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opioid use disorder (76.0%), alcohol use disorder (56.0%), and tobacco use disorder (81.6%). 
Nearly half of the sample (47.2%) met criteria for probable PTSD, and 64.0% met criteria for 
probable MDD. 
3.2 Latent class findings 
Table 2 presents the fit indices for each model tested. While the LMR LRT and the 
entropy values supported a 2-class model and the BIC supported a 3-class model, the AIC, SSA-
BIC, and the BLRT all supported a 4-class model. Given that the greatest support existed for the 
4-class solution, this model was selected for further examination. Class proportions are displayed 
in Table 1. The number of participants in each class was evenly distributed; class 1 consisted of 
23.7% of the sample, class 2 made up 25.1% of the sample, class 3 consisted of 22.7% of the 
sample, and class 4 made up 28.5% of the sample.  
 Class one was characterized as the PTSD-MDD-Poly SUD class. In this class, nearly 
85% of participants met criteria for probable PTSD and all met criteria for probable MDD. 
Regarding SUDs, 100% met criteria for opioid use disorder, nearly 90% of participants met 
criteria for tobacco use disorder, and approximately 65% met criteria for cannabis use disorder.  
Class two was characterized as the MDD-Poly SUD class. In this class, nearly 80% qualified for 
probable MDD, 100% qualified for alcohol use disorder, over 90% qualified for opioid use 
disorder, and approximately 80% met tobacco use disorder and cannabis use disorder criteria. 
Class three was characterized as the alcohol-tobacco SUD class. In this class, 100% had an 
alcohol use disorder, and nearly 75% had a tobacco use disorder. Finally, class four was 
characterized as the opioid-tobacco SUD class. In this class, nearly 100% had an opioid use 
disorder, and 84% had a tobacco use disorder.  
3.3 Class Differences  
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Means, standard deviations, and class differences on external variables are reported by 
class in Table 3. Analyses of class differences focused on differences between the PTSD-MDD-
Poly SUD class compared to the other classes given our hypothesis that subgroups displaying the 
greatest psychiatric comorbidity would report more severe addiction problems, more extensive 
psychiatric symptom severity, and would contain a greater proportion of women.  
Overall, those in the PTSD-MDD-Poly SUD class reported greater negative 
consequences resulting from their substance use compared to all other classes observed (MDD-
Poly SUD: MDiff  = 3.82, SE = 1.16, p = 0.007; alcohol-tobacco SUD: MDiff = 7.90, SE = 1.35, p < 
0.001; opioid-tobacco SUD: MDiff = 7.63, SE = 1.22, p < 0.001). In addition, they reported more 
severe opioid problems than all of the other classes, more severe cannabis, sedative, and cocaine 
problems than the alcohol-tobacco, and the opioid-tobacco SUD classes and more severe 
amphetamine problems than the alcohol-tobacco SUD class. However, they reported fewer 
alcohol problems than either the MDD-Poly SUD or the alcohol-tobacco SUD classes. 
In terms of trauma history, a greater proportion of the PTSD-MDD-Poly SUD class 
reported experiencing physical assault both before and after age 16 relative to the opioid-tobacco 
SUD class (physical assault <16: χ2[1] = 5.32, p = 0.02; physical assault > 16: χ2[1] = 9.36, p = 
0.02); while a greater proportion of participants in PTSD-MDD-Poly SUD class reported 
experiencing sexual assault both before and after age 16 compared to the alcohol-tobacco (sexual 
assault < 16: χ2[1] = 5.49, p = 0.02; sexual assault > 16: χ2[1] = 7.80, p = 0.005) and opioid-
tobacco classes (sexual assault < 16: χ2[1] = 13.83, p < 0.001; sexual assault > 16: χ2[1] = 13.25, 
p < 0.001).  
The PTSD-MDD-Poly SUD class also reported greater PTSD symptom severity 
compared to all of the other classes (MDD-Poly SUD: MDiff = 9.31, SE = 2.43, p = 0.001; 
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alcohol-tobacco SUD: MDiff = 17.27, SE = 2.59, p < 0.001; opioid-tobacco SUD: MDiff = 23.63, 
SE = 2.01, p < 0.001) and more severe MDD symptom severity relative to the alcohol-tobacco 
(MDiff = 19.67, SE = 2.51, p < 0.001) and the opioid-tobacco classes (MDiff = 19.00, SE = 2.11, p 
< 0.001).  
Finally, a greater proportion of the PTSD-MDD-Poly SUD class was comprised of 
females compared to all of the other classes (MDD-Poly SUD: χ2[1] = 10.97, p = 0.001; alcohol-
tobacco SUD: χ2[1] = 18.66, p < 0.001; opioid-tobacco SUD: χ2[1] = 9.57, p= 0.002). 
4. Discussion 
 The present results underscore the extent to which psychiatric comorbidity is prevalent 
among detoxification treatment-seekers; 47.2% of the sample met criteria for probable PTSD, 
and rates of probable PTSD were over 50% in half of the classes identified. Regarding probable 
MDD, 64% of the sample met criteria, and the rate of probable MDD ranged in the classes from 
40-79%. One difficulty in providing integrative treatment for PTSD-SUD comorbidity is 
adequately targeting polysubstance use and comorbid psychiatric disorders. This study used LCA 
to characterize the comorbidity patterns of probable PTSD, MDD, and SUDs and the clinical 
characteristics associated with those patterns in a sample of medical detoxification treatment-
seekers. The challenge of addressing multiple substances and comorbidities is heightened in the 
detoxification center treatment environment given the emphasis on short-term stabilization to 
facilitate the longer-term goal of recovery from addiction. 
 We identified four different and relatively equal sized classes: the PTSD-MDD-Poly 
SUD group, the MDD-Poly SUD group, the alcohol-tobacco SUD group, and the opioid-tobacco 
SUD group. The classes not characterized by polysubstance use were primarily differentiated by 
the presence of alcohol vs. opioid use disorders. Given that a 3-class solution has typically been 
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found to best describe the patterns of polysubstance use and comorbid psychiatric disorders, it is 
notable that we found evidence for a 4-class solution (Connor et al., 2013; Tomczyk et al., 2015; 
Galatzer-Levy et al., 2013). This is likely due to our use of a unique and understudied sample – 
detoxification treatment-seekers – which may have different characteristics than other samples. 
Further, we included comorbid psychiatric disorders as key variables (indicators) in the LCA 
rather than external variables examined post-LCA. In other words, we used probable MDD, 
PTSD, and multiple SUD diagnoses as variables to define the classes, rather than defining 
classes by substance and examining how MDD and PTSD varied among the classes post-hoc. 
The classes identified have implications for screening and referral processes used in the 
detoxification treatment setting. The MDD-Poly SUD class was characterized by high rates of 
both opioid and alcohol use disorders in comparison to the other classes. Given that alcohol use 
is present in nearly half of all fatal opioid overdoses (Warner-Smith, Darke, Lynskey, & Hall, 
2001), this group is at significant risk for overdose, underscoring the importance of addressing 
opioid use in the context of alcohol use for members of this class. Referrals to outpatient 
psychotherapy or in-house psychosocial interventions – in conjunction with pharmacotherapy 
utilizing naltrexone or naloxone – may be important for consolidating treatment gains made in 
detoxification and may be especially important to minimize the risk of fatal overdose.  
The variability of alcohol use disorders between classes is consistent with research 
suggesting that alcohol use disorders are highly heterogeneous. Following, future treatment 
research should focus on mechanisms specific to the cycles of alcohol addiction, such as greater 
emphasis on reducing negative affect during withdrawal early in treatment and tolerating craving 
later in treatment (Litten, et al., 2015). In addition, both the PTSD-MDD-Poly SUD and the 
MDD-Poly SUD classes were characterized by concurrent opioid and cannabis use disorders. 
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This finding is consistent with research implicating the endocannabinoid system in opioid 
dependence and the potential effectiveness of pharmacotherapies targeting the endocannabinoid 
system in alleviating opioid withdrawal during detoxification (Bisaga et al., 2015). 
Examination of key clinical characteristics indicated that people in the PTSD-MDD-Poly 
SUD class had more severe addiction problems as well as more severe PTSD/MDD symptom 
severity than people in other classes. In particular, it is notable that this class had more severe 
substance use problems even with respect to substances that were used less frequently (i.e., 
substances not characteristic of that LCA class). Not only were the symptoms of each individual 
disorder more severe, this class also had a more severe trauma history than other classes. Thus, 
trauma history characteristics of this class may be contributing factors to the elevated rates of 
probable PTSD and MDD observed. Notably, this class had more women, and women are more 
likely to experience interpersonal trauma (Black et al., 2011). Referrals to individual outpatient 
psychotherapy may be particularly important for long-term recovery for this group, especially 
women, given the reciprocal relationship between PTSD and SUD symptoms (Read et al., 2004). 
Women in this class who experience trauma symptoms arising from interpersonal violence may 
be less comfortable with mixed gender settings. 
Interventions that can target specific constructs or processes that are shared across 
disorders or diagnostic profiles are recommended. Many who seek detoxification continue to 
struggle one year later (Franken & Hendriks, 1999) suggesting that increasing the services 
offered at detoxification facilities or expanding referral networks based on baseline assessments 
of comorbidities may be fruitful for improving long-term recovery. For example, motivational 
interviews rather than advice regarding ongoing treatment have been associated with less 
substance use at follow-up (Vederhus, Timko, Kristensen, Hjemdahl, & Clausen, 2014), 
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illustrating the importance of providing brief interventions as part of the treatment planning 
process even when services are not provided at the detoxification facility. Motivational 
interviewing can be easily adapted for specific problems and is one way in which integrated 
treatment programs can be designed to match diagnostic profiles. For example, people in the 
PTSD-MDD-Poly SUD class may benefit more from motivational interviewing that discusses 
anxiety and avoidance symptoms whereas those in the alcohol-tobacco class may benefit from 
substance use focused motivational interviewing. 
Our results also point to transdiagnostic approaches in outpatient care to improve 
symptoms and reduce distress in a time- and cost-effective manner. Transdiagnostic 
interventions can be delivered as modules in group formats with each group targeting different 
processes. The groups could be offered simultaneously, and treatment-seekers could be referred 
to groups based on their diagnostic profiles. For example, interventions for anxiety sensitivity 
and nicotine replacement therapy could be offered simultaneously with referrals made based on 
comorbidity profile. Anxiety sensitivity has been shown to be amenable to a number of treatment 
approaches in a range of anxiety disorders (Lejuez et al., 2008). Anxiety sensitivity may be a 
useful target for the PTSD-MDD-Poly SUD class identified here. Another potential target is 
distress tolerance, which is related to anxiety sensitivity and strongly linked to substance use 
disorders (Buckner, Keough, & Schmidt, 2007). Newly developed interventions for distress 
tolerance have been well received by depressed substance use patients (Bornovalova, Gratz, 
Daughters, Hunt, & Lejuez, 2012). The brief interventions that have been developed for both 
anxiety sensitivity and distress tolerance have the potential to be easily combined with other 
treatment components to create integrated, multifaceted interventions that can be provided in 
short-term focused treatment settings or as transition pieces for longer term care. Distress 
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tolerance would be relevant for all the classes identified in this study and may be especially 
relevant for those in the PTSD-MDD-Poly SUD class given the elevated rates of probable PTSD 
and MDD that characterize members of this subgroup. Distress tolerance may be an especially 
useful skill to learn early in detoxification settings where treatment seekers may be experiencing 
acute, painful withdrawal symptoms. 
It should be noted that treatment-matching practices such as those proposed above have 
shown mixed benefits when applied in formal addiction treatment settings (e.g., Project MATCH 
Research Group, 1997). However, much past research specifically excluded detoxification 
seekers. It should be noted that the characteristics identified in Project MATCH that were 
associated with differential treatment outcome (severity of psychopathology, anger, desire for 
meaning making) are those which are elevated in PTSD-SUD comorbidity samples. Those 
studies showing success with integrative treatments (e.g., McLellan et al., 1997; Thornton, 
Gottheil, Weinstein, & Kerachsky, 1998) have demonstrated that integrative services are most 
appropriate for those patients presenting with the most complex clinical problems. This is 
consistent with our findings suggesting that those individuals in the PTSD-MDD-Poly SUD class 
may require additional resources compared to patients in the classes with less severe clinical 
presentations. For example, women are more likely to be in this class and more likely to 
experience treatment barriers related to childcare and parenting (Copeland, 1997). Thus referrals 
which can accommodate childcare needs are necessary; motivational interviewing and structured 
problem solving around these needs are also recommended. Even so, additional research 
replicating our findings should be performed to substantiate support for the existence of the 
classes observed. We also recommend future research examine differences in motivation and 
post-discharge treatment trajectories. 
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Self-report measures of PTSD and MDD were used to ascertain probable diagnoses; thus, 
the findings may be limited by the methodological constraints associated with self-report. 
Further, the assessment of depression is especially difficult in people who use substances as 
these symptoms could be caused by substance use and/or detoxification from substances. 
However, the PCL is highly correlated with clinician interview measures of PTSD (r = .93: 
Blanchard et al., 1996), and people who use substances may be more truthful in disclosing 
symptoms in self-report than interview formats (Islam et al., 2012). Second, the present study 
consists of individuals who were seeking medically assisted detoxification; these participants 
may have more severe symptoms or less social support than other treatment-seeking samples, 
and results may not generalize to all non-addiction samples. That said, detoxification treatment is 
an under-researched treatment setting in comparison to typical outpatient treatment, despite the 
unique features and public health importance of this setting. Finally, future research should 
examine a broader number of potential diagnostic comorbidities, particularly diagnoses 
associated with more challenging clinical presentations such as attention deficit-hyperactivity, 
bipolar, or borderline personality disorders. 
4.1 Conclusions 
In conclusion, the current study found evidence for differential patterns of PTSD-SUD-
MDD comorbidity in detoxification treatment seekers that indicate the need for tailored referral 
and treatment programs that can flexibly address specific substances or constructs. Integrative 
treatment approaches that include different components specialized to target different constructs 
that are associated with different diagnostic profiles (anxiety sensitivity, distress tolerance, 
opioid withdrawal, etc.,) are recommended as are referral networks which can identify settings 
and providers that offer these services.  
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Tables 
Table 1 
Class proportions (%) of indicator variables for the 4 class model, N = 375. 
Indicator PTSD-MDD-
Poly SUD (1) 
MDD-Poly 
SUD (2) 
Alcohol-
Tobacco (3) 
Opioid-  
Tobacco (4) 
Overall 
Prevalence 
 n = 89, 23.7% n = 94, 25.1% n = 85, 22.7% n = 107 , 28.5% N = 375 
PTSD 84.8 51.0 38.7 20.3 47.2 
MDD 100.0 79.0 41.8 40.2 64.0 
Opioid  100.0 91.2 0.0 99.0 76.0 
Alcohol  24.0 100.0 100.0 20.5 56.0 
Sedative  35.5 42.2 2.3 17.2 24.0 
Amphetamine  12.6 24.3 0.0 14.7 13.1 
Cocaine  34.8 52.2 13.3 10.0 26.1 
Tobacco  88.1 77.8 74.4 83.9 81.6 
Cannabis  64.7 76.3 27.8 43.4 52.5 
Note. Table numbers indicate the percentage of participants in the class classified by the diagnosis 
(indicator variable). Bolded values indicate the diagnoses that were characteristic (60% or greater) 
for that class. 
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Table 2 
Fit indices for latent class models 
Latent Class Models AIC BIC SSA-BIC LMR LRT BLRT Entropy 
2-class 3771.8 3846.4 3786.2 211.0*** 214.5*** 0.97 
3-class 3724.7 3838.6 3746.6 66.0 67.1*** 0.73 
4-class 3714.0 3867.1 3743.4 30.2 30.7*** 0.74 
5-class 3718.1 3910.5 3755.1 15.6 15.9 0.78 
Note. AIC = Akaike information criterion, BIC = Bayesian information criterion, SSA-BIC = 
sample size adjusted BIC, LMR LRT =, Lo-Mendell-Rubin likelihood ratio test, BLRT = 
Bootstrap likelihood ratio test 
** p <.01, ***p <.001 
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Table 3 
Means, standard deviations, prevalences, and statistical differences between the PTSD-MDD-Poly SUD class and other classes 
Variables PTSD-MDD-
Poly SUD (1) 
23.7% 
MDD-Poly 
SUD (2) 
25.1% 
Alcohol-
Tobacco (3) 
22.7% 
Opioid-
Tobacco (4) 
28.5% 
Statistical Test (omnibus) 
Opioid problems (M,SD) 31.8(5.8)abc 27.7(10.0)a 4.0(7.8)b 28.9(7.4)c F(3, 370) = 228.5, p < .001 
Alcohol problems (M,SD) 7.9(10.2)ab 19.6(13.4)a 32.4(7.1)b 6.0(8.0) F(3, 371) = 137.0, p < .001 
Cannabis problems (M,SD)  14.8(12.9)ab 13.2(11.2) 5.7(9.7)a 8.3(10.5)b F(3, 370) = 12.9, p < .001 
Sedative problems (M,SD) 11.5(12.5)ab 11.5(11.2) 4.1(8.0)a 6.3(8.6)b F(3, 370) = 12.1, p < .001 
Cocaine problems (M,SD) 13.1(12.8)ab 16.3(13.6) 4.8(9.8)a 5.3(8.4)b F(3, 370) = 24.1, p < .001 
Amphetamine problems (M,SD) 6.2(9.5)a 9.6(11.3) 1.7(5.2)a 5.7(9.3) F(3, 369) = 11.0, p < .001 
Tobacco problems (M,SD) 24.5(8.2) 21.7(9.0) 22.3(10.8) 21.7(8.22) F(3, 371) = 1.93, p = 0.12 
Negative consequences of use (M,SD) 40.7(6.2)abc 36.8(9.2)a 32.8(10.9)b 33.0(10.7)c F(3, 371) = 14.1, p < .001 
Physical assault pre 16 (% within class) 23.6%a 27.7% 22.4% 11.2%a χ2(3) = 9.2, p =.03 
Physical assault after 16 (% within class) 36.0%a 25.5% 24.7% 27.1%a χ2(3) = 9.4, p = .02 
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Sexual Assault pre 16 (% within class) 22.5%ab 17.0% 9.4%a 4.7%b χ2(3) = 15.9, p = .001 
Sexual Assault after 16 (% within class) 20.2%ab 17.0% 5.9%a 3.7%b χ2(3) = 18.5, p <.001 
PTSD severity (M,SD) 60.3(13.5)abc 51.0(19.0)a 43.0(19.8)b 36.6(14.6)c F(3, 371) = 35.2, p < .001 
MDD severity (M,SD) 61.6(11.2)ab 58.2(15.1) 42.0(20.5)a 42.6(18.1)b F(3, 371) = 35.5, p < .001 
Gender (% women within class) 59.6%abc 35.1%a 27.1%b 37.4%c  χ2(3) = 21.39, p <.001 
Note. Statistics with the same super script differ at the p < 0.05 significance level. 
 
